Laurion Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,980
| Closed | -$1.96M | – | 552 |
|
|
2026
Q1 | $1.96M | Buy |
+3,980
| New | +$2.16M | 0.09% | 217 |
|
|
2025
Q3 | – | Sell |
-1,175
| Closed | -$476K | – | 438 |
|
|
2025
Q2 | $476K | Buy |
+1,175
| New | +$491K | 0.01% | 256 |
|
|
2024
Q3 | – | Sell |
-50,406
| Closed | -$27.9M | – | 581 |
|
|
2024
Q2 | $27.9M | Sell |
50,406
-55,330
| -52% | -$31.7M | 0.33% | 57 |
|
|
2024
Q1 | $61.5M | Buy |
105,736
+53,498
| +102% | +$30M | 0.52% | 44 |
|
|
2023
Q4 | $27.7M | Buy |
+52,238
| New | +$25.3M | 0.23% | 90 |
|
|
2023
Q3 | – | Sell |
-10,169
| Closed | -$5.31M | – | 676 |
|
|
2023
Q2 | $5.31M | Buy |
+10,169
| New | +$5.49M | 0.03% | 259 |
|
|
2022
Q4 | – | Sell |
-5,570
| Closed | -$2.95M | – | 549 |
|
|
2022
Q3 | $2.83M | Buy |
5,570
+3,603
| +183% | +$2.02M | 0.02% | 299 |
|
|
2022
Q2 | $1.07M | Sell |
1,967
-33
| -2% | -$18.2K | 0.02% | 275 |
|
|
2022
Q1 | $1.18M | Buy |
+2,000
| New | +$1.15M | 0.01% | 241 |
|
|
2021
Q4 | – | Sell |
-2,587
| Closed | -$1.48M | – | 740 |
|
|
2021
Q3 | $1.48M | Buy |
2,587
+1,303
| +101% | +$715K | 0.01% | 471 |
|
|
2021
Q2 | $648K | Buy |
+1,284
| New | +$606K | ﹤0.01% | 482 |
|
|
2021
Q1 | – | Sell |
-582
| Closed | -$271K | – | 893 |
|
|
2020
Q4 | $271K | Sell |
582
-1,800
| -76% | -$844K | ﹤0.01% | 558 |
|
|
2020
Q3 | $1.05M | Buy |
+2,382
| New | +$984K | 0.01% | 415 |
|
|
2019
Q3 | – | Sell |
-2,600
| Closed | -$745K | – | 1285 |
|
|
2019
Q2 | $764K | Buy |
+2,600
| New | +$716K | 0.01% | 614 |
|
|
2019
Q1 | – | Sell |
-32,725
| Closed | -$7.32M | – | 1283 |
|
|
2018
Q4 | $7.32M | Buy |
32,725
+28,599
| +693% | +$6.71M | 0.13% | 214 |
|
|
2018
Q3 | $1.01M | Buy |
+4,126
| New | +$949K | 0.01% | 690 |
|
|
2018
Q2 | – | Sell |
-2,663
| Closed | -$550K | – | 1586 |
|
|
2018
Q1 | $550K | Buy |
+2,663
| New | +$559K | ﹤0.01% | 997 |
|
|
2016
Q4 | – | Sell |
-9,135
| Closed | -$1.35M | – | 1280 |
|
|
2016
Q3 | $1.45M | Buy |
9,135
+6,962
| +320% | +$1.07M | 0.01% | 525 |
|
|
2016
Q2 | $321K | Sell |
2,173
-4,927
| -69% | -$727K | 0.01% | 642 |
|
|
2016
Q1 | $1M | Buy |
+7,100
| New | +$952K | 0.02% | 425 |
|
|
2015
Q3 | – | Sell |
-2,009
| Closed | -$261K | – | 902 |
|
|
2015
Q2 | $261K | Buy |
+2,009
| New | +$262K | ﹤0.01% | 540 |
|
Other funds holding TMO
Laurion Capital Management's TMO Position: Q2 2026 in Review
Laurion Capital Management sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 3,980 shares — an estimated $1.96M sold.
Laurion Capital Management first reported a position in TMO in Q2 2015 and held it in 21 quarters. The position peaked at $61.5M in Q1 2024. 2,626 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Laurion Capital Management reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
- Laurion Capital Management sold 3,980 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.96M.
- Laurion Capital Management first reported a position in Thermo Fisher Scientific in Q2 2015 and held it in 21 quarters.
- Laurion Capital Management's Thermo Fisher Scientific position peaked at $61.5M in Q1 2024.
- 2,626 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.